Hanmi Pharmaceutical Shares Jump After Signing $2.31 Billion Licensing Deal With GenentechGlobal News Select Aug 24, 2026, 8:16:00 AM
Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity TherapyPR Newswire Aug 24, 2026, 4:40:00 AM
South Korean auto, pharma stocks rattled after Trump threatens to impose 25% tariffsMarketWatch Jan 27, 2026, 2:25:00 AM